Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grisham

Showing results (791-800 of 834) with videos related to

Pageof 84
Sort By:
Psychological Medicine|September 11, 2020
Imagery-enhanced <i>v.</i> verbally-based group cognitive behavior therapy for social anxiety disorder: a randomized clinical trialPeter M McEvoy, Matthew P Hyett, Samantha R Bank, et al.
Gynecologic Oncology|November 3, 2020
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancersMaria M Rubinstein, Rachel N Grisham, Karen Cadoo, et al.
Gynecologic Oncology|January 9, 2023
Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level - A Memorial Sloan Kettering Cancer Center studyRyan M Kahn, Erin McMinn, Effi Yeoshoua, et al.
Clinical and Translational Medicine|January 10, 2026
Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumoursRachel N Grisham, Elizabeth Hopp, Kathryn Pennington, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovaryLindsey Finch, Sarah Andres, Alexia Iasonos, et al.
Gastroenterology|September 11, 2012
Signaling lymphocyte activation molecule regulates development of colitis in miceBoaz van Driel, Gongxian Liao, Xavier Romero, et al.
Behaviour Research and Therapy|June 13, 2022
Impacts of imagery-enhanced versus verbally-based cognitive behavioral group therapy on psychophysiological parameters in social anxiety disorder: Results from a randomized-controlled trialPeter M McEvoy, Matthew P Hyett, Andrew R Johnson, et al.
Cancer|December 28, 2019
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathwayMaria M Rubinstein, David M Hyman, Imogen Caird, et al.
Gynecologic Oncology|November 12, 2021
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancerBeryl L Manning-Geist, Sushmita B Gordhandas, Dilip D Giri, et al.
Gynecologic Oncology|November 25, 2018
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockadeJulia L Boland, Qin Zhou, Madhuri Martin, et al.
Pageof 84

Showing results (791-800 of 834) with videos related to

Sort By:
Pageof 84
Psychological Medicine|September 11, 2020
Imagery-enhanced <i>v.</i> verbally-based group cognitive behavior therapy for social anxiety disorder: a randomized clinical trialPeter M McEvoy, Matthew P Hyett, Samantha R Bank, et al.
Gynecologic Oncology|November 3, 2020
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancersMaria M Rubinstein, Rachel N Grisham, Karen Cadoo, et al.
Gynecologic Oncology|January 9, 2023
Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level - A Memorial Sloan Kettering Cancer Center studyRyan M Kahn, Erin McMinn, Effi Yeoshoua, et al.
Clinical and Translational Medicine|January 10, 2026
Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumoursRachel N Grisham, Elizabeth Hopp, Kathryn Pennington, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovaryLindsey Finch, Sarah Andres, Alexia Iasonos, et al.
Gastroenterology|September 11, 2012
Signaling lymphocyte activation molecule regulates development of colitis in miceBoaz van Driel, Gongxian Liao, Xavier Romero, et al.
Behaviour Research and Therapy|June 13, 2022
Impacts of imagery-enhanced versus verbally-based cognitive behavioral group therapy on psychophysiological parameters in social anxiety disorder: Results from a randomized-controlled trialPeter M McEvoy, Matthew P Hyett, Andrew R Johnson, et al.
Cancer|December 28, 2019
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathwayMaria M Rubinstein, David M Hyman, Imogen Caird, et al.
Gynecologic Oncology|November 12, 2021
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancerBeryl L Manning-Geist, Sushmita B Gordhandas, Dilip D Giri, et al.
Gynecologic Oncology|November 25, 2018
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockadeJulia L Boland, Qin Zhou, Madhuri Martin, et al.
Pageof 84